Menu

ISTOCK, STEINPHOTO

Proposed EPA “Transparency” Rule Criticized

Opponents of the guidelines, which would bar results of many public health studies from use in policy making, include scientific and healthcare organizations.

Jul 18, 2018
Shawna Williams

A proposed rule purportedly aimed at strengthening the transparency of the Environmental Protection Agency’s decision-making process would gut environmental regulations that protect human health, critics argued at a public hearing yesterday at the EPA (July 17). The rule would require that the data underlying any studies used to craft the agency’s policies be publicly available—a bar that would be impossible to reach for many public health studies that rely on confidential health information.

“This would have chilling consequences for the EPA and every person who benefits from clean air and clean water. . . . This proposed rule is an administrative attempt to circumvent the legislative process,” testified US Representative Suzanne Bonamici (D-OR).

See “EPA Seeks to Restrict the Science Used in Policymaking

According to The Atlantic, the guidelines, proposed in April, appear to target regulations that limit particulate air pollution. They are backed by a 1993 study showing that Americans living in cities with higher particulate levels suffered health consequences. That study was the “biggest science fraud that has gone on in this country’s history,” Steven Milloy of the conservative Heartland Institute tells The Atlantic

Other backers of the rule include members of industry trade groups, the Associated Press reports, but critics outnumbered supporters at yesterday’s hearing. The proposal has also drawn opposition from the editors of scientific journals and dozens of public health, medical, academic, and scientific groups.

“If the EPA wanted to engage in a good-faith discussion in how to improve transparency, that’s certainly something they could have done,” Jeremy Berg, the editor-in-chief of Science, tells The Atlantic. “But this doesn’t seem to be that.” 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.